IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and …
Over the last 12 months, insiders at IQVIA Holdings Inc. have bought $0 and sold $20.2M worth of IQVIA Holdings Inc. stock.
On average, over the past 5 years, insiders at IQVIA Holdings Inc. have bought $5.19M and sold $267.76M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $2.73M was made by DANHAKL JOHN G (director) on 2021‑12‑22.
2024-08-27 | Sale | See Remarks | 1,300 0.0007% | $246.33 | $320,229 | -5.56% | ||
2024-03-01 | Sale | See Remarks | 31,678 0.0173% | $250.53 | $7.94M | -7.39% | ||
2024-02-29 | Sale | See Remarks | 14,100 0.0078% | $247.80 | $3.49M | -5.33% | ||
2024-02-28 | Sale | See Remarks | 8,607 0.0047% | $250.17 | $2.15M | -6.50% | ||
2024-02-16 | Sale | See Remarks | 1,000 0.0006% | $241.50 | $241,500 | -1.60% | ||
2024-02-16 | Sale | See Remarks | 13,468 0.0075% | $241.10 | $3.25M | -1.60% | ||
2023-12-01 | Sale | See Remarks | 13,117 0.0071% | $214.03 | $2.81M | +6.73% | ||
2023-09-19 | Sale | See Remarks | 27,317 0.0149% | $208.67 | $5.7M | +8.27% | ||
2023-06-05 | Sale | See Remarks | 5,820 0.0031% | $201.89 | $1.17M | +7.35% | ||
2023-05-26 | Sale | See Remarks | 1 <0.0001% | $198.66 | $199 | +9.64% | ||
2023-02-16 | Sale | See Remarks | 4,446 0.0024% | $225.61 | $1M | -5.61% | ||
2023-02-16 | Sale | See Remarks | 2,772 0.0015% | $225.57 | $625,280 | -5.61% | ||
2023-02-14 | Sale | See Remarks | 1,000 0.0005% | $230.00 | $230,000 | -6.88% | ||
2021-12-22 | director | 10,000 0.0052% | $272.93 | $2.73M | -20.82% | |||
2021-11-29 | Sale | director | 555,094 0.2865% | $262.60 | $145.77M | -17.15% | ||
2021-10-25 | Sale | See Remarks | 4 <0.0001% | $256.93 | $1,028 | -11.47% | ||
2021-09-23 | See Remarks | 4 <0.0001% | $262.82 | $1,051 | -10.85% | |||
2021-08-16 | Sale | See Remarks | 6,055 0.0031% | $250.00 | $1.51M | -5.88% | ||
2021-07-20 | See Remarks | 13 <0.0001% | $245.32 | $3,189 | -1.47% | |||
2020-12-23 | director | 63,451 0.0334% | $176.95 | $11.23M | +38.01% |
Bruehlman Ronald E | See Remarks | 26224 0.0144% | $219.69 | 3 | 1 | +1.55% |
DANHAKL JOHN G | director | 24344 0.0134% | $219.69 | 2 | 8 | +8.59% |
Lo Annie H. | director | 2062 0.0011% | $219.69 | 1 | 0 | +18.13% |
The Vanguard Group | $5.33B | 11.56 | 21.07M | -0.05% | -$2.51M | 0.1 | |
BlackRock | $3.89B | 8.45 | 15.39M | +1.48% | +$56.6M | 0.09 | |
Harris Associates | $2.57B | 5.57 | 10.14M | +4.06% | +$100.02M | 4.15 | |
State Street | $2.01B | 4.37 | 7.96M | +0.54% | +$10.88M | 0.08 | |
AllianceBernstein | $1.07B | 2.32 | 4.22M | -10.85% | -$129.93M | 0.38 |